GF
ABMD

Gerstein Fisher’s Abiomed Inc ABMD Stock Holding History

Gerstein Fisher’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.17M Hold
32,426
– – 0.51% 34
2016
Q2 		$3.54M Sell
32,426
-77
-0.2% -$7.66K 0.46% 36
2016
Q1 		$3.08M Hold
32,503
– – 0.42% 41
2015
Q4 		$2.93M Sell
32,503
-99
-0.3% -$8.4K 0.41% 41
2015
Q3 		$3.02M Hold
32,602
– – 0.45% 35
2015
Q2 		$2.14M Buy
+32,602
New +$2.17M 0.35% 54

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gerstein Fisher's ABMD Position: Q3 2016 in Review

Gerstein Fisher held its Abiomed Inc (ABMD) position steady in Q3 2016 at 32,426 shares worth $4.17M. The position accounts for 0.51% of the portfolio, ranked #34.

Gerstein Fisher first reported a position in ABMD in Q2 2015 and has held it in 6 quarters since. 305 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

  • Gerstein Fisher held 32,426 shares of Abiomed Inc worth $4.17M as of Q3 2016.
  • Gerstein Fisher left its Abiomed Inc share count unchanged in Q3 2016.
  • Abiomed Inc made up 0.51% of Gerstein Fisher's portfolio in Q3 2016, its #34 holding.
  • Gerstein Fisher first reported a position in Abiomed Inc in Q2 2015 and has held it in 6 quarters since.
  • 305 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.